Literature DB >> 28063096

Feasibility of in vivo three-dimensional T 2* mapping using dicarboxy-PROXYL and CW-EPR-based single-point imaging.

Harue Kubota1, Denis A Komarov1, Hironobu Yasui2, Shingo Matsumoto1, Osamu Inanami3, Igor A Kirilyuk4, Valery V Khramtsov5, Hiroshi Hirata6.   

Abstract

OBJECTIVES: The aim of this study was to demonstrate the feasibility of in vivo three-dimensional (3D) relaxation time T 2* mapping of a dicarboxy-PROXYL radical using continuous-wave electron paramagnetic resonance (CW-EPR) imaging.
MATERIALS AND METHODS: Isotopically substituted dicarboxy-PROXYL radicals, 3,4-dicarboxy-2,2,5,5-tetra(2H3)methylpyrrolidin-(3,4-2H2)-(1-15N)-1-oxyl (2H,15N-DCP) and 3,4-dicarboxy-2,2,5,5-tetra(2H3)methylpyrrolidin-(3,4-2H2)-1-oxyl (2H-DCP), were used in the study. A clonogenic cell survival assay was performed with the 2H-DCP radical using squamous cell carcinoma (SCC VII) cells. The time course of EPR signal intensities of intravenously injected 2H,15N-DCP and 2H-DCP radicals were determined in tumor-bearing hind legs of mice (C3H/HeJ, male, n = 5). CW-EPR-based single-point imaging (SPI) was performed for 3D T 2* mapping.
RESULTS: 2H-DCP radical did not exhibit cytotoxicity at concentrations below 10 mM. The in vivo half-life of 2H,15N-DCP in tumor tissues was 24.7 ± 2.9 min (mean ± standard deviation [SD], n = 5). The in vivo time course of the EPR signal intensity of the 2H,15N-DCP radical showed a plateau of 10.2 ± 1.2 min (mean ± SD) where the EPR signal intensity remained at more than 90% of the maximum intensity. During the plateau, in vivo 3D T 2* maps with 2H,15N-DCP were obtained from tumor-bearing hind legs, with a total acquisition time of 7.5 min.
CONCLUSION: EPR signals of 2H,15N-DCP persisted long enough after bolus intravenous injection to conduct in vivo 3D T 2* mapping with CW-EPR-based SPI.

Entities:  

Keywords:  Clonogenic assay; In vivo EPR; In vivo nitroxyl radical kinetics; Nitroxyl radical; Single-point imaging; T 2 * mapping

Mesh:

Substances:

Year:  2017        PMID: 28063096      PMCID: PMC5518941          DOI: 10.1007/s10334-016-0606-8

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  39 in total

1.  Application of continuous-wave EPR spectral-spatial image reconstruction techniques for in vivo oxymetry: comparison of projection reconstruction and constant-time modalities.

Authors:  Ken-ichiro Matsumoto; Baby Chandrika; Joost A B Lohman; James B Mitchell; Murali C Krishna; Sankaran Subramanian
Journal:  Magn Reson Med       Date:  2003-10       Impact factor: 4.668

2.  Clonogenic assay of cells in vitro.

Authors:  Nicolaas A P Franken; Hans M Rodermond; Jan Stap; Jaap Haveman; Chris van Bree
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

3.  Detection of the kinetics of biochemical reactions with oxygen using exchange broadening in the ESR spectra of nitroxide radicals.

Authors:  J M Backer; V G Budker; S I Eremenko; Y N Molin
Journal:  Biochim Biophys Acta       Date:  1977-04-11

4.  Interaction of melanin with oxygen.

Authors:  T Sarna; A Duleba; W Korytowski; H Swartz
Journal:  Arch Biochem Biophys       Date:  1980-03       Impact factor: 4.013

5.  Mapping the spin-density and lineshape distribution of free radicals using 4D spectral-spatial EPR imaging.

Authors:  P Kuppusamy; M Chzhan; A Samouilov; P Wang; J L Zweier
Journal:  J Magn Reson B       Date:  1995-05

Review 6.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

7.  The influence of oxygen on the E.S.R. spectrum of a radiosensitizing nitroxide.

Authors:  A J Hoff; R Deen
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1971

8.  EPR and DNP properties of certain novel single electron contrast agents intended for oximetric imaging.

Authors:  J H Ardenkjaer-Larsen; I Laursen; I Leunbach; G Ehnholm; L G Wistrand; J S Petersson; K Golman
Journal:  J Magn Reson       Date:  1998-07       Impact factor: 2.229

9.  Pulsed EPR imaging of nitroxides in mice.

Authors:  Fuminori Hyodo; Shingo Matsumoto; Nallathamby Devasahayam; Christopher Dharmaraj; Sankaran Subramanian; James B Mitchell; Murali C Krishna
Journal:  J Magn Reson       Date:  2008-12-24       Impact factor: 2.229

10.  Echo-based Single Point Imaging (ESPI): a novel pulsed EPR imaging modality for high spatial resolution and quantitative oximetry.

Authors:  Sankaran Subramanian; Nallathamby Devasahayam; Shingo Matsumoto; Keita Saito; James B Mitchell; Murali C Krishna
Journal:  J Magn Reson       Date:  2012-04-05       Impact factor: 2.229

View more
  5 in total

1.  Modular imaging system: Rapid scan EPR at 800 MHz.

Authors:  Oxana Tseytlin; Priyaankadevi Guggilapu; Andrey A Bobko; Hussien AlAhmad; Xuan Xu; Boris Epel; Ryan O'Connell; Emily H Hoblitzell; Timothy D Eubank; Valery V Khramtsov; Benoit Driesschaert; Eiad Kazkaz; Mark Tseytlin
Journal:  J Magn Reson       Date:  2019-06-08       Impact factor: 2.229

2.  Rapid Scan EPR imaging as a Tool for Magnetic Field Mapping.

Authors:  Oxana Tseytlin; Andrey A Bobko; Mark Tseytlin
Journal:  Appl Magn Reson       Date:  2020-09-25       Impact factor: 0.831

Review 3.  In Vivo Molecular Electron Paramagnetic Resonance-Based Spectroscopy and Imaging of Tumor Microenvironment and Redox Using Functional Paramagnetic Probes.

Authors:  Valery V Khramtsov
Journal:  Antioxid Redox Signal       Date:  2017-12-20       Impact factor: 8.401

4.  Data processing of 3D and 4D in-vivo electron paramagnetic resonance imaging co-registered with ultrasound. 3D printing as a registration tool.

Authors:  M Gonet; B Epel; M Elas
Journal:  Comput Electr Eng       Date:  2019-01-30       Impact factor: 3.818

5.  Algebraic reconstruction of 3D spatial EPR images from high numbers of noisy projections: An improved image reconstruction technique for high resolution fast scan EPR imaging.

Authors:  Denis A Komarov; Alexandre Samouilov; Rizwan Ahmad; Jay L Zweier
Journal:  J Magn Reson       Date:  2020-08-25       Impact factor: 2.229

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.